Article
Generation and therapeutic efficacy of the novel Fc-modified cross-neutralizing human monoclonal antibodies against dengue virus
2023-05-26
Abstract excerpt
<h4>Background: </h4> Dengue disease is a mosquito-borne infection caused by four dengue virus serotypes (DENV1–4). Secondary infections can produce flavivirus cross-reactive antibodies at sub-neutralizing levels. This phenomenon can significantly increase the severity of secondary infections via antibody-dependent enhancement (ADE). ADE activity is associated with a high risk of viral infection in immune effector...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9f62b88d-7f0f-5a67-a8cf-95adfece7fe8
- DOI
- 10.1101/2023.05.25.542225
